Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SN vs GSK✓SelectedUSD · GSKSN vs GSK performance historyLatest closeAs of-5.78%11/19
Stock and ETF performance explorer

SN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+424.6%
GSK return
+54.2%
Excess return
+370.4%
Maximum drawdown
-42.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.8%-1.6%-4.2%-5.6%
7D-1.5%-4.7%+3.2%-0.9%
30D+9.1%-4.7%+13.8%+9.8%
3M+19.6%-8.8%+28.4%+20.9%
6M+112.6%-4.6%+117.2%+113.5%
YTD+93.7%+1.0%+92.8%+94.3%
1Y+148.1%+6.9%+141.2%+147.9%
3Y+382.5%+52.5%+330.0%+320.9%
All+424.6%+54.2%+370.4%+353.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling